U.S. Pharma Stock News

Why Adobe is on investors’ radar right now With no single headline event driving attention, Adobe (ADBE) is drawing interest as investors weigh its recent share performance, current valuation signals, and the scale of its digital media and experience businesses. See our latest analysis for Adobe. Adobe’s share price has been choppy, with a 2.6% 1 day decline and a 19.8% 90 day share price return. At the same time, the 1 year total shareholder return of 36.6% and 5 year total shareholder...

Harrow, Inc. recently reported fourth-quarter 2025 sales of US$89.09 million and full-year 2025 revenue of US$272.30 million, issued 2026 revenue guidance of US$350 million to US$365 million, and received FDA clearance of an IND to run a Phase 3 trial of TRIESENCE for ocular inflammation and pain after cataract surgery. The combination of strong recent revenue performance, ambitious 2026 guidance, and progress toward potentially broadening TRIESENCE’s on-label cataract surgery use has...

Starboard Value has publicly pressed Lamb Weston Holdings (LW) to double its cost savings program, sharpen cuts to SG&A, and consider selling select Asia Pacific assets, putting cost discipline and portfolio choices firmly in focus for investors. See our latest analysis for Lamb Weston Holdings. That activist letter lands after a tough period for the stock, with a 30 day share price return of an 11.25% decline and a 3 year total shareholder return of a 52.07% decline. This suggests momentum...

PepsiCo stock snapshot after recent share performance PepsiCo (PEP) has seen a 0.5% decline over the past day and a 2.5% pullback over the past week, with the shares down about 5.7% over the past month. See our latest analysis for PepsiCo. That recent pullback comes after a stronger run earlier in the year, with PepsiCo’s year to date share price return of 13.0% and 1 year total shareholder return of 9.8% pointing to momentum that has cooled in the past month. If PepsiCo’s mixed momentum has...

In early March 2026, Texas Capital Securities upgraded Brunswick Corporation to Buy, highlighting the company’s market leadership and favorable positioning in the recreational marine industry amid expectations of a boating demand recovery. Coming shortly after Brunswick’s first annual revenue increase in three years and ongoing tariff headwinds, the upgrade underscores how sharply investor sentiment can shift as analysts reassess the company’s role in the boating ecosystem. Now we’ll explore...

In the past few days, Zeta Global Holdings reported its 18th consecutive quarter of exceeding expectations, with fourth-quarter revenue growing 25% year over year and Super-Scaled Customers increasing 24% as its AI-powered marketing platform gained further traction. An interesting angle for investors is how Zeta’s AI engine, which analyzes over one trillion consumer signals monthly, appears to be translating into larger, higher-value customer relationships and recurring platform usage across...

The Kroger Co. recently reported fourth-quarter 2025 results showing sales of US$34,725 million and net income of US$861 million, while full-year net income fell to US$1.02 billion on largely flat sales of US$147.64 billion. Alongside these results, Kroger completed multi-billion-dollar share repurchases and outlined modest identical sales guidance plus new private-label meal launches, signaling a push to sharpen value and customer appeal under its new leadership. Next, we’ll examine how...

What triggered the latest interest in Parker-Hannifin? Parker-Hannifin (PH) is back in focus after its fiscal 2026 earnings estimate was revised upward, tied to constructive trends in manufacturing, product development spending, and steady aerospace demand across both original equipment and aftermarket channels. See our latest analysis for Parker-Hannifin. Against this backdrop, Parker-Hannifin’s share price has eased over the past month, with a 30 day share price return of a 2.67% decline...

Bicara Therapeutics recently completed a public offering that raised approximately US$172.5 million through the sale of common stock and pre-funded warrants, and its CEO Claire Mazumdar sold 8,234 shares following stock option exercises between March 4 and March 6, 2026. This capital raise materially strengthens Bicara’s funding for ongoing clinical programs, while insider activity and new long-term follow-up data provide additional context on the company’s progress. We’ll now examine how...

DocuSign, Inc. recently appointed Brian Roberts as an independent Class I director to fill an existing board vacancy, with his term running through the 2028 Annual Meeting of Stockholders in line with Nasdaq and Securities Act independence standards. This board change comes as DocuSign rolls out new AI-powered agreement tools and tests revamped eSignature pricing, highlighting governance oversight during a key product and pricing transition. Now we’ll examine how Roberts’s board appointment,...

Bristow Group (NYSE:VTOL) joined the U.S. Department of Transportation’s eVTOL Integration Pilot Program. The company is partnering with Elroy Air to deploy the Chaparral autonomous cargo drone. The program targets aerial cargo delivery opportunities for the energy sector along the U.S. Gulf Coast. Bristow Group, best known for crew transport and search and rescue services, is now stepping into autonomous aerial cargo through its work with Elroy Air. By participating in the U.S. Department...

If you are trying to work out whether Disc Medicine is attractively priced today, it helps to first look at how the market has been treating the stock and what that might imply about expectations. The share price recently closed at US$66.18, with returns of 2.8% over the last 7 days, a 17.0% decline over 30 days, a 16.3% decline year to date, and a 22.8% gain over the past year. Taken together, this gives you a mixed picture of sentiment and risk. Recent news coverage around Disc Medicine...

eToro Group (NasdaqGS:ETOR) has completed a significant share buyback tranche. The company repurchased nearly 4% of its shares outstanding. This buyback represents a material capital allocation move for existing and prospective shareholders. eToro Group runs a multi asset investment platform that gives users access to equities, cryptoassets and other instruments. This position places the company at the intersection of retail trading and digital finance. As regulators around the world keep a...

PayPal Holdings (NasdaqGS:PYPL) has been named a key participant in Mastercard's new global Crypto Partner Program. The company is expanding industry collaborations, including live tests for blockchain based digital asset settlement in transportation finance. PayPal is also working on payment orchestration for retail, tying its digital wallet and processing tools into broader cross border payment flows. These moves come while the company continues to deal with ongoing legal matters and...

In early March 2026, IREN Limited entered purchase agreements for over 50,000 Nvidia B300 GPUs, aiming to expand its AI-focused fleet to 150,000 units and planning phased deployment through the second half of 2026 across existing data centers in British Columbia and Texas. An interesting angle is that IREN is funding this rapid AI build-out with around US$9.30 billion already secured and about US$3.50 billion of additional 2026 capex planned, while also adding an at-the-market equity program...

Dycom Industries (DY) stock came under pressure after the company paired record fiscal 2026 results with a softer margin outlook and more cautious revenue guidance for fiscal 2027, prompting a clear sell the news reaction. See our latest analysis for Dycom Industries. Those concerns have come after a sharp run, with Dycom’s share price now at US$362.97, a 1 year total shareholder return of about 152% and a 5 year total shareholder return just under 3x. Recent 7 and 30 day share price returns...

ICL Group Ltd. has announced that longtime CFO Aviram Lahav will retire on June 15, 2026, with experienced finance executive Asaf Alperovitz, currently CFO of SolarEdge Technologies, set to assume the CFO role and join the executive management team on that date. This planned transition brings a leader with extensive public-company and global finance experience into ICL’s top ranks, a move that could influence how the company executes its growth-focused strategy and manages capital allocation...

In early March 2026, Bristol Myers Squibb reported positive interim Phase 3 SUCCESSOR-2 results for oral mezigdomide in relapsed or refractory multiple myeloma and secured U.S. FDA approval for Sotyktu (deucravacitinib) to treat adults with active psoriatic arthritis, expanding its presence in hematology and immunology. Together, these developments highlight Bristol Myers Squibb’s depth in targeted protein degradation and TYK2 inhibition, underscoring how its research platforms can translate...

Short-seller report and leadership upheaval put GPGI in focus A short-seller report on GPGI (GPGI) questioning the financials of its Husky Technologies acquisition, together with recent CEO and CFO resignations, has put leadership stability and deal execution under close investor scrutiny. See our latest analysis for GPGI. After the short seller report and leadership changes, the share price has retreated, with a 1 month share price return of 19% and a 7 day share price return of 10.4%,...

In early March 2026, Ashtead Group completed its U.S. redomiciliation, rebranded as Sunbelt Rentals Holdings, shifted its primary listing from the London Stock Exchange to the New York Stock Exchange, and replaced PwC UK with PwC US as its independent auditor for the fiscal year ending April 30, 2026. The move aligns the listed entity, governance structure and audit oversight with Sunbelt Rentals’ largely North American operations, potentially improving investor familiarity and access to...

Janus Henderson Group (NYSE:JHG) has rejected an unsolicited acquisition bid from Victory Capital. The board unanimously backed its earlier support for a transaction involving Trian Fund Management and General Catalyst instead. Directors cited execution risks and client reservations with the Victory Capital approach while reiterating confidence in the Trian and General Catalyst deal. Janus Henderson Group, a global asset manager, operates in a sector where scale, distribution reach, and...

Why Assured Guaranty (AGO) is on investors’ radar today Assured Guaranty (AGO) is drawing fresh attention after recent trading left the stock around $84.95, with returns over the past month and past 3 months both in negative territory. For investors, the current share level sits against a backdrop of annual revenue of about $832 million and net income of roughly $499 million, alongside mixed annual trends in revenue and net income growth. See our latest analysis for Assured Guaranty. While...

If you are wondering whether Texas Capital Bancshares is still reasonably priced at around US$92.16, you are not alone. The stock now sits at a level where valuation really starts to matter. The share price has recorded a 3.5% decline over the last 7 days and an 11.8% decline over the last 30 days, although it is still up 0.5% year to date and 30.1% over the past year, with a 66.1% return over 3 years and 6.2% over 5 years. Recent trading interest has been shaped by ongoing coverage of US...

Natera, Inc. recently reported full-year 2025 results, issued 2026 revenue guidance of US$2.62 billion to US$2.70 billion, filed a US$183.08 million employee stock offering shelf, and shared new clinical data on its Signatera test at the 2026 ASCO Genitourinary Cancers Symposium and multiple investor conferences. The new Signatera data in muscle-invasive bladder cancer, showing strong links between ctDNA/utDNA-based residual disease detection and patient outcomes, highlight how Natera’s...